- Report
- October 2025
- 182 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2025
- 278 Pages
Global
From €5233EUR$5,850USD£4,603GBP
- Report
- April 2025
- 200 Pages
Global
From €4016EUR$4,490USD£3,533GBP
- Report
- June 2025
- 400 Pages
Global
From €4427EUR$4,949USD£3,894GBP
- Report
- August 2025
- 190 Pages
Global
From €3171EUR$3,545USD£2,789GBP
€3523EUR$3,939USD£3,099GBP
- Report
- October 2023
- 226 Pages
Global
From €4159EUR$4,650USD£3,659GBP
- Report
- August 2024
- 100 Pages
Global
From €5322EUR$5,950USD£4,681GBP
- Report
- January 2024
- 200 Pages
Global
From €3712EUR$4,150USD£3,265GBP
- Report
- October 2023
- 146 Pages
Global
From €3155EUR$3,528USD£2,775GBP
€3712EUR$4,150USD£3,265GBP
- Report
- July 2023
- 124 Pages
Global
From €3500EUR$4,192USD£3,186GBP
-
Journal - October 2025
- 64 Pages
Global
From €380EUR$425USD£334GBP
The Drug and Gene Delivery market within the context of Genomics is a rapidly growing field of research and development. It involves the use of various technologies to deliver drugs and genes to specific cells or tissues in the body. This can be done through a variety of methods, such as viral vectors, liposomes, nanoparticles, and other delivery systems. These technologies are used to treat a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders.
The Drug and Gene Delivery market is driven by the increasing demand for personalized medicine, as well as the need for more effective treatments for diseases. Additionally, advances in gene editing technologies have enabled the development of more precise and targeted therapies.
Some of the major players in the Drug and Gene Delivery market include Novartis, Merck, Pfizer, Sanofi, and AstraZeneca. Other companies in the market include Amgen, GlaxoSmithKline, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more
